Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family

被引:300
作者
Goding, JW
Grobben, B
Slegers, H
机构
[1] Univ Instelling Antwerp, Dept Biomed Sci Cellular Biochem, B-2610 Antwerp, Belgium
[2] Monash Univ, Monash Med Sch, Dept Pathol & Immunol, Prahran, Vic 3181, Australia
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2003年 / 1638卷 / 01期
关键词
nucleotide pyrophosphatase; bone mineralization; purinergic receptor signalling; cell motility; type; 2; diabetes;
D O I
10.1016/S0925-4439(03)00058-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ecto-nucleotide pyrophosphatase/phosphodiesterase (E-NPP) multigene family contains five members. NPP1-3 are type II transmembrane metalloenzymes characterized by a similar modular structure composed of a short intracellular domain, a single transmembrane domain and an extracellular domain containing a conserved catalytic site. The short intracellular domain of NPP1 has a basolateral membrane-targeting signal while NPP3 is targeted to the apical surface of polarized cells. NPP4-5 detected by database searches have a predicted type I membrane orientation but have not yet been functionally characterized. E-NPPs have been detected in almost all tissues often confined to specific substructures or cell types. In some cell types, NPP1 expression is constitutive or can be induced by TGF-beta and glucocorticoids, but the signal transduction pathways that control expression are poorly documented. NPP1-3 have a broad substrate specificity which may reflect their role in a host of physiological and biochemical processes including bone mineralization, calcification of ligaments and joint capsules, modulation of purinergic receptor signalling, nucleotide recycling, and cell motility. Abnormal NPP expression is involved in pathological mineralization, crystal depositions in joints, invasion and metastasis of cancer cells, and type 2 diabetes. In this review we summarize the present knowledge on the structure and the physiological and biochemical functions of E-NPP and their contribution to the pathogenesis of diseases. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 19
页数:19
相关论文
共 210 条
[51]   Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects - Evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling [J].
Frittitta, L ;
Spampinato, D ;
Solini, A ;
Nosadini, R ;
Goldfine, ID ;
Vigneri, R ;
Trischitta, V .
DIABETES, 1998, 47 (07) :1095-1100
[52]   Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-alpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity [J].
Frittitta, L ;
Youngren, JF ;
Sbraccia, P ;
DAdamo, M ;
Buongiorno, A ;
Vigneri, R ;
Goldfine, ID ;
Trischitta, V .
DIABETOLOGIA, 1997, 40 (03) :282-289
[53]   A cluster of three single nucleotide polymorphisms in the 3′-untranslated region of human glycoprotein PC-1 gene stabilizes PC-1 mRNA and is associated with increased PC-1 protein content and insulin resistance-related abnormalities [J].
Frittitta, L ;
Ercolino, T ;
Bozzali, M ;
Argiolas, A ;
Graci, S ;
Santagati, MG ;
Spampinato, D ;
Di Paola, R ;
Cisternino, C ;
Tassi, V ;
Vigneri, R ;
Pizzuti, A ;
Trischitta, V .
DIABETES, 2001, 50 (08) :1952-1955
[54]   A soluble PC-1 circulates in human plasma: Relationship with insulin resistance and associated abnormalities [J].
Frittitta, L ;
Camastra, S ;
Baratta, R ;
Costanzo, BV ;
D'Adamo, M ;
Graci, S ;
Spampinato, D ;
Maddux, BA ;
Vigneri, R ;
Ferrannini, E ;
Trischitta, V .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3620-3625
[55]   MOLECULAR-CLONING OF CDNAS FOR HUMAN FIBROBLAST NUCLEOTIDE PYROPHOSPHATASE [J].
FUNAKOSHI, I ;
KATO, H ;
HORIE, K ;
YANO, T ;
HORI, Y ;
KOBAYASHI, H ;
INOUE, T ;
SUZUKI, H ;
FUKUI, S ;
TSUKAHARA, M ;
KAJII, T ;
YAMASHINA, I .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 295 (01) :180-187
[56]  
Fuss B, 1997, J NEUROSCI, V17, P9095
[57]  
GARVEY WT, 1993, BAILLIERE CLIN ENDOC, V7, P785
[58]   Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases [J].
Gijsbers, R ;
Ceulemans, H ;
Stalmans, W ;
Bollen, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1361-1368
[59]   Ecto-nucleotide pyrophosphatase modulates the purinoceptor-mediated signal transduction and is inhibited by purinoceptor antagonists [J].
Grobben, B ;
Claes, P ;
Roymans, D ;
Esmans, EL ;
Van Onckelen, H ;
Slegers, H .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) :139-145
[60]   An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma [J].
Grobben, B ;
Anciaux, K ;
Roymans, D ;
Stefan, C ;
Bollen, M ;
Esmans, EL ;
Slegers, H .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) :826-834